Nov 10, 2015
István Gábor Takács
Cost-effective Yet Underfunded: The Harm Reduction Program of Odyseus in Slovakia
In Slovakia, the cost/benefit analysis carried out on a needle and syringe exchange program showed that every euro invested in C.A. Odyseus´s harm reduction program generated benefits worth almost three euros. Read what the figures show about why it’s worthwhile investing in harm reduction!










